Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 4
1997 2
1999 3
2000 1
2001 5
2002 6
2003 7
2004 5
2005 13
2006 12
2007 7
2008 8
2009 8
2010 9
2011 10
2012 8
2013 5
2014 10
2015 10
2016 9
2017 8
2018 12
2019 3
2020 8
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all
Page 1
Jiménez-Lima R, Arango-Bravo E, Galicia-Carmona T, Lino-Silva LS, Trejo-Durán GE, Alvarado-Silva C, Castañeda-Renderos OH, Vanoye-Carlo EG, Torre CF, Dueñas-González A, Cetina-Pérez L. Jiménez-Lima R, et al. Among authors: duenas gonzalez a. Rev Invest Clin. 2020;72(4):231-238. doi: 10.24875/RIC.20000060. Rev Invest Clin. 2020. PMID: 33064705 Free article. Review.
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
Dueñas-González A, Zarbá JJ, Patel F, Alcedo JC, Beslija S, Casanova L, Pattaranutaporn P, Hameed S, Blair JM, Barraclough H, Orlando M. Dueñas-González A, et al. J Clin Oncol. 2011 May 1;29(13):1678-85. doi: 10.1200/JCO.2009.25.9663. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444871 Clinical Trial.
Therapy-related myelodysplastic syndrome.
Candelaria M, Dueñas-Gonzalez A. Candelaria M, et al. Among authors: duenas gonzalez a. Expert Opin Drug Saf. 2015 May;14(5):655-65. doi: 10.1517/14740338.2015.1014340. Epub 2015 Feb 12. Expert Opin Drug Saf. 2015. PMID: 25675961 Review.
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A, Chávez-Blanco A, Domínguez-Gómez G, Taja-Chayeb L, Morales-Barcenas R, Trejo-Becerril C, Perez-Cardenas E, Gonzalez-Fierro A, Dueñas-González A. Schcolnik-Cabrera A, et al. Among authors: duenas gonzalez a. Expert Opin Investig Drugs. 2018 May;27(5):475-489. doi: 10.1080/13543784.2018.1471132. Epub 2018 May 10. Expert Opin Investig Drugs. 2018. PMID: 29723075 Review.
Perspectives on Drug Repurposing.
Schcolnik-Cabrera A, Juárez-López D, Duenas-Gonzalez A. Schcolnik-Cabrera A, et al. Among authors: duenas gonzalez a. Curr Med Chem. 2021;28(11):2085-2099. doi: 10.2174/0929867327666200831141337. Curr Med Chem. 2021. PMID: 32867630
Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A, Dueñas-González A. Gonzalez-Fierro A, et al. Among authors: duenas gonzalez a. Semin Cancer Biol. 2021 Jan;68:123-131. doi: 10.1016/j.semcancer.2019.12.012. Epub 2019 Dec 23. Semin Cancer Biol. 2021. PMID: 31877340 Review.
Emerging drugs for cervical cancer.
Dueñas-Gonzalez A, Cetina L, Coronel J, Cervantes-Madrid D. Dueñas-Gonzalez A, et al. Expert Opin Emerg Drugs. 2012 Jun;17(2):203-18. doi: 10.1517/14728214.2012.683409. Epub 2012 Apr 25. Expert Opin Emerg Drugs. 2012. PMID: 22530838 Review.
Hereditary diffuse gastric cancer (HDGC). An overview.
Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Taja-Chayeb L, et al. Among authors: duenas gonzalez a. Clin Res Hepatol Gastroenterol. 2021 Oct 14;46(4):101820. doi: 10.1016/j.clinre.2021.101820. Online ahead of print. Clin Res Hepatol Gastroenterol. 2021. PMID: 34656755 Review.
167 results